3/17
08:00 pm
aapg
Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026
Low
Report
Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026
3/14
06:58 am
aapg
Ascentage Pharma Group International (AAPG) was upgraded by BTIG Research to "strong-buy".
Medium
Report
Ascentage Pharma Group International (AAPG) was upgraded by BTIG Research to "strong-buy".
3/12
08:03 am
aapg
Ascentage Pharma Group International (AAPG) had its "buy" rating reaffirmed by BTIG Research. They now have a $48.00 price target on the stock.
Low
Report
Ascentage Pharma Group International (AAPG) had its "buy" rating reaffirmed by BTIG Research. They now have a $48.00 price target on the stock.
3/11
08:00 am
aapg
Ascentage Pharma to Report Full Year 2025 Unaudited Financial Results and Provide Business Updates on March 25, 2026
Medium
Report
Ascentage Pharma to Report Full Year 2025 Unaudited Financial Results and Provide Business Updates on March 25, 2026
2/23
08:00 am
aapg
Ascentage Pharma to Participate in Three Upcoming Investor Conferences
Low
Report
Ascentage Pharma to Participate in Three Upcoming Investor Conferences
2/9
08:00 am
aapg
Ascentage Pharma to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
Medium
Report
Ascentage Pharma to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
2/5
06:30 pm
aapg
Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288
Low
Report
Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288
1/14
08:25 pm
aapg
Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference
1/13
10:58 am
aapg
Ascentage Pharma Group International (NASDAQ:AAPG) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $48.00 price target on the stock.
Medium
Report
Ascentage Pharma Group International (NASDAQ:AAPG) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $48.00 price target on the stock.
1/6
08:00 pm
aapg
Ascentage Pharma Announces IND Clearance by the U.S. Food and Drug Administration for BTK Degrader APG-3288
Medium
Report
Ascentage Pharma Announces IND Clearance by the U.S. Food and Drug Administration for BTK Degrader APG-3288